2022 |
Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055)) |
Nota o commento |
Vai |
2021 |
Diabetic foot ulcers: Retrospective comparative analysis from Sicily between two eras |
Articolo in rivista |
Vai |
2021 |
Predictive factors of polycystic ovary syndrome in girls with precocious pubarche |
Articolo in rivista |
Vai |
2021 |
Perception of the role of food and dietary modifications in patients with inflammatory bowel disease: Impact on lifestyle |
Articolo in rivista |
Vai |
2020 |
The association between education level and chronic liver disease of any etiology |
Articolo in rivista |
Vai |
2020 |
Recurrent sacrococcygeal pilonidal disease: the efficacy of minimal subcutaneous excision of the sinus and unroofing of pseudocystic cavity |
Articolo in rivista |
Vai |
2019 |
Decreasing role of HCV and HBV infections as aetiological factors of hepatocellular carcinoma in Italy |
Articolo in rivista |
Vai |
2019 |
Erratum: Characteristics of patients with hepatitis C virus-related chronic liver diseases just before the era of oral direct-acting antiviral therapy in Italy (European Journal of Gastroenterology and Hepatology (2018) 30 (676-681) DOI: 10.1097/MEG.0000000000001099) |
Articolo in rivista |
Vai |
2018 |
Rivaroxaban-induced hepatotoxicity: review of the literature and report of new cases |
Articolo in rivista |
Vai |
2018 |
Geographical pattern of chronic liver diseases in Italy: Results from two pooled national surveys |
Articolo in rivista |
Vai |
2018 |
Anti-tumour necrosis factor-α antibodies and B cell homeostasis in human inflammatory bowel diseases |
Articolo in rivista |
Vai |
2018 |
Characteristics and Changes over Time of Alcohol-Related Chronic Liver Diseases in Italy |
Abstract in rivista |
Vai |
2018 |
Necrotizing Soft Tissue Fasciitis after Intramuscular Injection |
Articolo in rivista |
Vai |
2018 |
The burden of HBV infection in HCV patients in Italy and the risk of reactivation under DAA therapy |
Articolo in rivista |
Vai |
2018 |
Characteristics of patients with hepatitis C virus-related chronic liver diseases just before the era of oral direct-acting antiviral therapy in Italy |
Articolo in rivista |
Vai |
2017 |
Influence of universal HBV vaccination on chronic HBV infection in Italy: Results of a cross-sectional multicenter study |
Articolo in rivista |
Vai |
2017 |
Characteristics of liver cirrhosis in Italy: Evidence for a decreasing role of HCV aetiology |
Articolo in rivista |
Vai |
2017 |
End-stage pancreatic adenocarcinoma presenting as a sister Mary Joseph's nodule |
Articolo in rivista |
Vai |
2017 |
Simeprevir and daclatasvir for 12 or 24 weeks in treatment-naïve patients with hepatitis C virus genotype 1b and advanced liver disease |
Articolo in rivista |
Vai |
2017 |
Safety and efficacy of a fixed-dose combination regimen of grazoprevir, ruzasvir, and uprifosbuvir with or without ribavirin in participants with and without cirrhosis with chronic hepatitis C virus genotype 1, 2, or 3 infection (C-CREST-1 and C-CREST-2, part B): two randomised, phase 2, open-label trials |
Articolo in rivista |
Vai |
2017 |
Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication |
Articolo in rivista |
Vai |
2017 |
Etiological factors of chronic hepatitis in Italy: A 2014 national survey |
Articolo in rivista |
Vai |
2017 |
Sex difference in the interaction of alcohol intake, hepatitis B virus, and hepatitis C virus on the risk of cirrhosis |
Articolo in rivista |
Vai |
2017 |
Hepatitis delta infection in Italian patients: towards the end of the story? |
Articolo in rivista |
Vai |
2017 |
Gender differences in chronic liver diseases in two cohorts of 2001 and 2014 in Italy |
Articolo in rivista |
Vai |
2016 |
Clinical course and genetic susceptibility of primary biliary cirrhosis: Analysis of a prospective cohort |
Articolo in rivista |
Vai |
2016 |
Epidemiological and clinical scenario of chronic liver diseases in Italy: Data from a multicenter nationwide survey |
Articolo in rivista |
Vai |
2015 |
Gender differences in chronic HBsAg carriers in Italy: Evidence for the independent role of male sex in severity of liver disease |
Articolo in rivista |
Vai |
2015 |
Blood urea nitrogen to creatinine ratio is associated with congestion and mortality in heart failure patients with renal dysfunction |
Articolo in rivista |
Vai |
2015 |
Clinical course and management of acute and chronic viral hepatitis during pregnancy. |
Review essay (rassegna critica) |
Vai |
2015 |
A functional study of the esophagus in patients with non-cardiac chest pain and dysphagia |
Articolo in rivista |
Vai |
2015 |
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways |
Articolo in rivista |
Vai |
2015 |
Meccanismi immunologici e molecolari del danno epatico da farmaci |
Articolo in rivista |
Vai |
2015 |
12 weeks of interferon-based therapy is feasible in patients with hepatitis C-related cirrhosis and thrombocytopenia: A post hoc analysis of eltrombopag studies |
Articolo in rivista |
Vai |
2015 |
Tumor Necrosis Factor Alpha Antagonists and Occurrence of Autoantibodies in Inflammatory Bowel Disease Patients: A Single Center Experience |
Articolo in rivista |
Vai |
2015 |
Significance of serum Il-9 levels in inflammatory bowel disease |
Articolo in rivista |
Vai |
2014 |
Liver function test abnormalities in patients with inflammatory bowel diseases: A hospital-based survey |
Articolo in rivista |
Vai |
2014 |
HCV E1E2-MF59 vaccine in chronic hepatitis C patients treated with PEG-IFNα2a and Ribavirin: a randomized controlled trial. |
Articolo in rivista |
Vai |
2014 |
Clinical features and outcomes of patients with drug-induced autoimmune hepatitis: A retrospective cohort study. |
Articolo in rivista |
Vai |
2014 |
Pegylated interferon α plus ribavirin for the treatment of chronic hepatitis C: a multicentre independent study supported by the Italian Drug Agency. |
Articolo in rivista |
Vai |
2013 |
Fibrosis Evaluation by Transient Elastography in Patients With Long-Term Sustained HCV Clearance |
Articolo in rivista |
Vai |
2013 |
In vivo liver expression of TLR2, TLR3 and TLR7 in chronic hepatitis C |
Articolo in rivista |
Vai |
2013 |
Mortality risk according to different clinical characteristics of first episode of liver decompensation in cirrhotic patients: a nationwide, prospective, 3-year follow-up study in Italy. |
Articolo in rivista |
Vai |
2013 |
Clinical course and prognostic factors of hepatorenal syndrome: A retrospective single-center cohort study |
Articolo in rivista |
Vai |
2013 |
Morphological distribution of μ chains and cd15 receptors in colorectal polyp and adenocarcinoma specimens. |
Abstract in rivista |
Vai |
2013 |
MECCANISMI IMMUNOLOGICI E MOLECOLARI DEL DANNO EPATICO DA FARMACI |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
2013 |
Esophageal motility changes after thyroidectomy; possible associations with postoperative voice and swallowing disorders: preliminary results. |
Articolo in rivista |
Vai |
2012 |
HCV Prevalence in Italy an Epidemiological, Observational, Cross-Sectional, Multicenter Study Participating Centers. |
Articolo in rivista |
Vai |
2012 |
Unusual B cell morphology in inflammatory bowel disease. |
Articolo in rivista |
Vai |
2012 |
Serology in adults with celiac disease: limited accuracy in patients with mild histological lesions. |
Articolo in rivista |
Vai |
2012 |
Esophageal motility changes after thyroidectomy:
possible associations with postoperative voice
and swallowing disorders |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
2012 |
Current practice of chronic hepatitis B treatment in Southern Italy. |
Articolo in rivista |
Vai |
2012 |
Impact of comorbidities on the severity of chronic hepatitis B at presentation. |
Abstract in rivista |
Vai |
2012 |
Overcoming a "probable" diagnosis in antimitochondrial antibody negative primary biliary cirrhosis: study of 100 sera and review of the literature. |
Articolo in rivista |
Vai |
2012 |
DISTRIBUTION OF ESOPHAGEAL DYSMOTILITIES AMONG PATIENTS WITH NON-CARDIAC CHEST PAIN, DYSPHAGIA OR BOTH |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
2011 |
Management of hepatitis C virus genotype 4: recommendations of an international expert panel. |
Articolo in rivista |
Vai |
2011 |
The optimal dose of ribavirin for chronic hepatitis C: From literature evidence to clinical practice: The optimal dose of ribavirin for chronic hepatitis C. |
Articolo in rivista |
Vai |
2011 |
Chronic hepatitis C infection and insulin resistance: two best friends. |
Articolo in rivista |
Vai |
2011 |
Recommendations for the prevention, diagnosis, and treatment of chronic hepatitis B and C in special population groups (migrants, intravenous drug users and prison inmates). |
Articolo in rivista |
Vai |
2011 |
The impact of antiviral therapy and the influence of metabolic cofactors on the outcome of chronic HCV infection. |
Articolo in rivista |
Vai |
2011 |
Management of hepatitis B virus infection in the underprivileged world. |
Articolo in rivista |
Vai |
2011 |
Pegylated-interferon-α(2a) in clinical
practice: how to manage patients suffering from side effects |
Articolo in rivista |
Vai |
2011 |
B lymphocyte intestinal homing in inflammatory bowel disease. |
Articolo in rivista |
Vai |
2010 |
Genome-wide meta-analyses identify three loci associated with primary biliary
cirrhosis. |
Articolo in rivista |
Vai |
2010 |
Retrospective, observational, multicentre study on an Italian population affected by chronic hepatitis C who failed to clear HCV-RNA after the combined therapy (PEG-IFN and ribavirin): NADIR study |
Articolo in rivista |
Vai |
2010 |
Current practice of hepatitis C treatment in Southern Italy. |
Articolo in rivista |
Vai |
2010 |
Smoking as a cofactor for causation of chronic pancreatitis: a meta-analysis. |
Articolo in rivista |
Vai |
2010 |
Interaction of alcohol intake and cofactors on the risk of cirrhosis. |
Articolo in rivista |
Vai |
2010 |
Sustained virologic response prevents the development of esophageal varices in compensated, Child-Pugh class A hepatitis C virus-induced cirrhosis. A 12-year prospective follow-up study. |
Articolo in rivista |
Vai |
2010 |
Clinical course and outcomes of drug-induced liver injury: Nimesulide as the first implicated medication. |
Articolo in rivista |
Vai |
2009 |
PEG-INTERFERON PLUS RIBAVIRIN IN COMPENSATED HCV CIRRHOSIS WITH PORTAL HYPERTENSION: THE ROLE OF RAPID AND EARLY VIROLOGICAL RESPONSE IN PREDICTING THE SUSTAINED VIROLOGICAL RESPONSE |
Abstract in rivista |
Vai |
2009 |
Predicting mortality risk in patients with compensated HCV-induced cirrhosis: a long-term prospective study. |
Articolo in rivista |
Vai |
2009 |
HCV genotypes in Sicily: is there any evidence of a shift? |
Articolo in rivista |
Vai |
2009 |
Serum BLyS/BAFF predicts the outcome of acute hepatitis C virus infection |
Articolo in rivista |
Vai |
2009 |
Noninvasive assessment of liver fibrosis in thalassaemia major patients by transient elastography (TE) - lack of interference by iron deposition. |
Articolo in rivista |
Vai |
2009 |
Small intestine bacterial overgrowth and irritable bowel syndrome-related symptoms: experience with Rifaximin. |
Articolo in rivista |
Vai |
2009 |
Pharmacological Treatment of Patients with Chronic Critical Limb Ischemia: L-Propionyl-Carnitine Enhances the Short-Term Effects of PGE-1 |
Articolo in rivista |
Vai |
2009 |
PEG_interferon plus Ribavirin in compensated HCV cirrhosis with portal hypertension: the role of rapid and early virological response in predicting the sustained virological response |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
2009 |
Evolving clinical landscape of chronic hepatitis B: A multicenter Italian study. |
Articolo in rivista |
Vai |
2009 |
PEG-interferon plus Ribavirin in compensated HCV cirrhosis with portal hypertension: the role of rapid and early virological response in predicting the sustained virological response |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
2009 |
HALT-C in the final analysis: a molehill out of a mountain. |
Articolo in rivista |
Vai |
2008 |
Serum BLYS/BAFF levels in acute hepatitis C predict clinical outcome |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
2008 |
Liver disease in chelated transfusion-dependent thalassemics: the role of iron and chronic hepatitis C |
Articolo in rivista |
Vai |
2008 |
Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: a multicenter study of 664 patients and 1992 healthy controls. |
Articolo in rivista |
Vai |
2008 |
Prospective, randomized, crossover comparison of sublingual apomorphine (3 mg)
with oral sildenafil (50 mg) for male erectile dysfunction. |
Articolo in rivista |
Vai |
2008 |
Chronic hepatitis B in Italy: new features of an old disease--approaching the
universal prevalence of hepatitis B e antigen-negative cases and the eradication
of hepatitis D infection. |
Articolo in rivista |
Vai |
2008 |
HCV genotypes in western Sicily: any evidence for a shift? |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
2008 |
Lack of correlation between serum anti-HBcore detectability and hepatocellular
carcinoma in patients with HCV-related cirrhosis. |
Articolo in rivista |
Vai |
2008 |
New therapeutic prospects in HCV treatment. |
Articolo in rivista |
Vai |
2008 |
Liver disease in chelated transfusion-dependent thalassemics: the role of iron overload and chronic hepatitis C. |
Articolo in rivista |
Vai |
2008 |
Inguinal hernioplasty improves the quality of life in patients with cirrhosis. |
Articolo in rivista |
Vai |
2008 |
CLINICAL COURSE OF NIMESULIDE-INDUCED LIVER INJURY |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
2007 |
The impact of sustained virological response on clinical outcomes in compensated HCV cirrhosis: a prospective cohort study |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
2007 |
Therapy expectations and physical comorbidity affect quality of life in chronic hepatitis C virus infection. |
Articolo in rivista |
Vai |
2007 |
Peg-interferon alone or combined with ribavirin in HCV cirrhosis with portal hypertension:a randomized controlled trial |
Articolo in rivista |
Vai |
2007 |
HCV infection is a risk factor for gallstone disease in liver cirrhosis: an
Italian epidemiological survey. |
Articolo in rivista |
Vai |
2007 |
Botulinum toxin vs. topical glyceryl trinitrate ointment for pain control in patients undergoing hemorrhoidectomy: a randomized trial. |
Articolo in rivista |
Vai |
2007 |
Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: a retrospective study. |
Articolo in rivista |
Vai |
2007 |
Impact of hepatitis C virus infection on lifestyle. |
Articolo in rivista |
Vai |
2007 |
The impact of insulin resistance, serum adipocytokines and visceral obesity on steatosis and fibrosis in patients with chronic hepatitis C. |
Articolo in rivista |
Vai |
2007 |
STAGING OF FIBROSIS BY LIVER STIFFNESS MEASUREMENT IN THALASSEMICS WITH IRON OVERLOAD |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
2007 |
The impact of sustained virological response on clinical outcome in compensated HCV cirrhosis: a prospective cohort study |
Proceedings (TIPOLOGIA NON ATTIVA) |
Vai |
2007 |
STORIA NATURALE DELLA CIRROSI EPATICA |
Capitolo o Saggio |
Vai |
2007 |
Long-term manometric study of anal sphincter function after hemorrhoidectomy. |
Articolo in rivista |
Vai |
2006 |
Epidemiology and clinical course of drug-induced liver injury |
Articolo in rivista |
Vai |
2006 |
Iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis and the quality of life: a new therapeutic protocol |
Articolo in rivista |
Vai |
2006 |
Different doses of consensus interferon plus ribavirin in patients with hepatitis C virus genotype 1 relapsed after interferon monotherapy: a randomized controlled trial |
Articolo in rivista |
Vai |
2006 |
The effect of antiviral therapy on clinical outcome of HCV cirrhosis with portal hypertension: a prospective cohort study. |
Articolo in rivista |
Vai |
2006 |
Exposure to HAV infection in patients with chronic liver disease in Italy, a multicentre study*. |
Articolo in rivista |
Vai |
2006 |
Small bowel angiodysplasia associated with von Willebrand's disease: report of a case |
Articolo in rivista |
Vai |
2006 |
Influence of liver disease staging on sustained virological response in HCV “Favourable” genotypes treated with PEG-interferon and ribavirin: Data from clinical practice |
Articolo in rivista |
Vai |
2006 |
Kinetic analysis of insulin resistance and serum adipocytokines levels during peginterferon alpha-2A plus ribavirin therapy in non-diabetic HCV patients |
Articolo in rivista |
Vai |
2006 |
Characteristics of HCV positive subjects referring to hospitals in Italy: a multicentre prevalence study on 6,999 cases |
Articolo in rivista |
Vai |
2006 |
Granular cell tumor of stomach: a case report and review of literature. |
Articolo in rivista |
Vai |
2006 |
High rate of spontaneous viral clearance in patients with iatrogenic acute hepatitis C |
Articolo in rivista |
Vai |
2005 |
Experts' opinions on the role of liver biopsy in HCV infection: a Delphi survey by the Italian Association of Hospital Gastroenterologists (A.I.G.O.) |
Articolo in rivista |
Vai |
2005 |
Acute polymyositis during treatment of acute hepatitis C with pegylated interferon alpha-2b |
Articolo in rivista |
Vai |
2005 |
HBV-DNA suppression and disease course in HBV cirrhosis patients on long-term lamivudine therapy |
Articolo in rivista |
Vai |
2005 |
Trends of aetiological factors of hepatocellular carcinoma in Italy |
Articolo in rivista |
Vai |
2005 |
The importance of HCV on the burden of chronic liver disease in Italy: a multicenter prevalence study of 9,997 cases |
Articolo in rivista |
Vai |
2005 |
Improvement of wound healing after hemorrhoidectomy: a double-blind, randomized study of botulinum toxin injection |
Articolo in rivista |
Vai |
2004 |
PROSPECTIVE, RANDOMIZED, CROSSOVER COMPARISON OF SUBLINGUAL APOMORPHINE (3 mg) WITH ORAL SILDENAFIL (50 mg) FOR MALE ERECTILE DYSFUNCTION |
Articolo in rivista |
Vai |
2004 |
A woman with a long history of abdominal pain |
Articolo in rivista |
Vai |
2004 |
The aetiology of chronic hepatitis in Italy: results from a multicentre national study |
Articolo in rivista |
Vai |
2004 |
The aetiological pattern of hepatocellular carcinoma ( HCC) in Italy is changing |
Abstract in rivista |
Vai |
2004 |
Weight-based dosing: which impact on efficacy and safety of therapy? |
Articolo in rivista |
Vai |
2004 |
Characteristics of liver cirrhosis in Italy: results from a multicenter national study |
Articolo in rivista |
Vai |
2004 |
Clinical outcome of HBeAg-negative chronic hepatitis B in relation to virological response to lamivudine |
Articolo in rivista |
Vai |
2004 |
Treating chronic hepatitis C in daily practice with PEG-IFN alfa2B and ribavirin. An Italian multicentre study |
Abstract in rivista |
Vai |
2003 |
Occult HBV infection and suppression of HCV replication in the early phase of combination therapy for chronic hepatitis C |
Articolo in rivista |
Vai |
2003 |
IL-10 and TNF-α polymorphisms and the recovery from HCV infection |
Articolo in rivista |
Vai |
2002 |
Early viral clearance and sustained response in chronic hepatitis C: a controlled trial of interferon and ribavirin after high-dose interferon induction |
Articolo in rivista |
Vai |
2002 |
Anti-hepatitis A virus seroprevalence and seroconversion in a cohort of patients with chronic viral hepatitis |
Articolo in rivista |
Vai |
2002 |
TUMORI a CELLULE GERMINALIin ETA' PEDIATRICA: FATTORI PROGNOSTICI del PROTOCOLLO AIEOP TCG 91. |
Articolo in rivista |
Vai |